Tabs
Bruce Fireman, MA; Kaiser Permanente Northern California, Oakland, CA
Susan Gruber, PhD, MPH, MS; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Laura Amsden, MSW, MPH; Bruce Fireman, MA; Kaiser Permanente Northern California, Oakland, CA
Jessica Franklin, PhD; Joshua Gagne, PharmD, ScD; Sebastian Schneeweiss, MD, ScD; Shirley Wang, PhD, ScM; Richie Wyss, PhD; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Katherine Freitas; Susan Gruber, PhD; Judith Maro, PhD, MS; Catherine Rogers, MPH; Darren Toh, ScD; Zilu Zhang, MS; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Christian Hampp, PhD; Mark Levenson, PhD; Michael Nguyen, MD; Yueqin Zhao, PhD, MS; Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Rima Izem, PhD; Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Jennifer Nelson, PhD; Robert Wellman MS; Kaiser Permanente Washington Health Research Institute, Seattle, WA